The Relationship between Serous Choroidal Detachment and the Ahmed Glaucoma Valve Failure.

IF 1.2 Q3 OPHTHALMOLOGY

Journal of Current Ophthalmology Pub Date : 2025-01-18 eCollection Date: 2024-04-01 DOI:10.4103/joco.joco_245_23

Maryam Yadgari, Ahmad Shojaei Baghini, Fatemeh Vafaei, Behnoosh Attarian, Mohammadmehdi Hatami, Kourosh Sheibani, Sadid Hooshmandi

{"title":"The Relationship between Serous Choroidal Detachment and the Ahmed Glaucoma Valve Failure.","authors":"Maryam Yadgari, Ahmad Shojaei Baghini, Fatemeh Vafaei, Behnoosh Attarian, Mohammadmehdi Hatami, Kourosh Sheibani, Sadid Hooshmandi","doi":"10.4103/joco.joco_245_23","DOIUrl":null,"url":null,"abstract":"Purpose: To investigate the effect of serous choroidal detachment (SCD) on the success of Ahmed glaucoma valve (AGV) implantation.Methods: Patients who underwent AGV implantation and developed SCD were included in the case group. The control group was matched based on age, sex, baseline intraocular pressure (IOP), glaucoma type, and the number of glaucoma medications. The patient data were retrospectively extracted from available records. The primary outcome measure was an AGV success rate based on 5 < IOP <18 and a 20% reduction from baseline.Results: Seventeen patients were enrolled in the case group and 38 in the control group. Preoperative visual acuity of patients was 1.17 ± 0.43 and 1.16 ± 0.37 logMAR in the case and control groups, respectively. The patients in the case group showed higher mean IOP at all time intervals compared to controls. However, the mean IOP only reached a statistically significant difference at 3 months (17.94 ± 6.78 mmHg vs. 13.39 ± 3.09 mmHg, P = 0.003). The mean survival duration was significantly shorter in patients with SCD (10.4 ± 0.7 months vs. 11.7 ± 0.2 months for controls log-rank = 4.1, P = 0.04). The cumulative probability of success was 76.5% in patients with SCD and 94.7% in the control group after 12 months.Conclusions: SCD after AGV implantation could be a risk factor for failure. A larger prospective study with a longer follow-up duration is required to confirm the present study results.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 2","pages":"129-135"},"PeriodicalIF":1.2000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11856118/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/joco.joco_245_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To investigate the effect of serous choroidal detachment (SCD) on the success of Ahmed glaucoma valve (AGV) implantation.

Methods: Patients who underwent AGV implantation and developed SCD were included in the case group. The control group was matched based on age, sex, baseline intraocular pressure (IOP), glaucoma type, and the number of glaucoma medications. The patient data were retrospectively extracted from available records. The primary outcome measure was an AGV success rate based on 5 < IOP <18 and a 20% reduction from baseline.

Results: Seventeen patients were enrolled in the case group and 38 in the control group. Preoperative visual acuity of patients was 1.17 ± 0.43 and 1.16 ± 0.37 logMAR in the case and control groups, respectively. The patients in the case group showed higher mean IOP at all time intervals compared to controls. However, the mean IOP only reached a statistically significant difference at 3 months (17.94 ± 6.78 mmHg vs. 13.39 ± 3.09 mmHg, P = 0.003). The mean survival duration was significantly shorter in patients with SCD (10.4 ± 0.7 months vs. 11.7 ± 0.2 months for controls log-rank = 4.1, P = 0.04). The cumulative probability of success was 76.5% in patients with SCD and 94.7% in the control group after 12 months.

Conclusions: SCD after AGV implantation could be a risk factor for failure. A larger prospective study with a longer follow-up duration is required to confirm the present study results.

查看原文本刊更多论文

浆液性脉络膜脱离与Ahmed青光眼瓣膜失效的关系。

目的：探讨浆液性脉络膜脱离（SCD）对Ahmed青光眼瓣膜（AGV）植入术成功的影响。方法：将接受AGV植入并发生SCD的患者作为病例组。对照组根据年龄、性别、基线眼压（IOP）、青光眼类型和青光眼药物数量进行匹配。回顾性地从现有记录中提取患者资料。主要结局指标是基于5 < IOP结果的AGV成功率：17例患者入组病例组，38例患者入组对照组。病例组和对照组术前视力分别为1.17±0.43、1.16±0.37 logMAR。与对照组相比，病例组患者在所有时间间隔内均表现出较高的平均IOP。然而，平均IOP仅在3个月时达到统计学意义上的差异（17.94±6.78 mmHg vs. 13.39±3.09 mmHg, P = 0.003）。SCD患者的平均生存时间明显较短（10.4±0.7个月，对照组为11.7±0.2个月，log-rank = 4.1, P = 0.04）。12个月后，SCD患者的累计成功率为76.5%，对照组为94.7%。结论：AGV植入后SCD可能是AGV植入失败的危险因素。需要更大的前瞻性研究和更长的随访时间来证实目前的研究结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Current Ophthalmology OPHTHALMOLOGY-

CiteScore

2.50

自引率

6.70%

发文量

审稿时长

8 weeks

期刊介绍： Peer Review under the responsibility of Iranian Society of Ophthalmology Journal of Current Ophthalmology, the official publication of the Iranian Society of Ophthalmology, is a peer-reviewed, open-access, scientific journal that welcomes high quality original articles related to vision science and all fields of ophthalmology. Journal of Current Ophthalmology is the continuum of Iranian Journal of Ophthalmology published since 1969.